Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
4-(P-TRIFLUOROMETHYLBENZYL)-3-FLORO-1,2,4 TRIPHENYLAMINE DERIVATIVE, PHARMACEUTICAL COMPOSITION OF SAME, AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/001298
Kind Code:
A1
Abstract:
Provided in the present invention are a 4-(p-trifluoromethylbenzyl)-3-floro-1,2,4 triphenylamine derivative, a pharmaceutical composition of same, and uses thereof. The chemical formula of the derivative is as represented by formula I, where R is a C1-C6 alkyl, a cycloalkyl, a heteroatom-containing cycloalkyl, an aromatic ring, or a heteroatom-containing aromatic ring, the heteroatom is selected from N or O; n is 0, 1, 2, or 3; and the pharmaceutical composition has any of the 4-(p-trifluoromethylbenzyl)-3-floro-1,2,4 triphenylamine derivatives described above as the active ingredient and, at the same time, contains one or more pharmaceutically acceptable carrier. The derivative and the pharmaceutical composition are provided with a significantly activated KCNQ channel current; therefore, the derivative is applicable in preparing a KCNQ potassium channel opener, also applicable as an active ingredient of an antiepileptic medicinal preparation, and as an active ingredient of an anxiety relieving medicinal preparation and of a neuropathic pain relieving medicinal preparation.

Inventors:
ZHANG HAILIN (CN)
QI JINLONG (CN)
JIA QINGZHONG (CN)
DU XIAONA (CN)
HAO HAN (CN)
Application Number:
PCT/CN2019/091365
Publication Date:
January 02, 2020
Filing Date:
June 14, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV HEBEI MEDICAL (CN)
International Classes:
A61K31/167; C07C231/02; A61K31/341; A61K31/4465; A61P25/02; A61P25/08; A61P25/22; A61P29/00; C07C233/43; C07C233/44; C07D211/34; C07D295/15; C07D307/54
Domestic Patent References:
WO2016077724A12016-05-19
Foreign References:
CN108707087A2018-10-26
CN1761464A2006-04-19
CN101056845A2007-10-17
Attorney, Agent or Firm:
SHIJIAZHUANG GUOYU PATENT TRADEMARK AGENCY et al. (CN)
Download PDF: